Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context.
about
Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Outcomes and costs of Ranibizu ...... alth-service research context.
@en
Outcomes and costs of Ranibizu ...... alth-service research context.
@nl
type
label
Outcomes and costs of Ranibizu ...... alth-service research context.
@en
Outcomes and costs of Ranibizu ...... alth-service research context.
@nl
prefLabel
Outcomes and costs of Ranibizu ...... alth-service research context.
@en
Outcomes and costs of Ranibizu ...... alth-service research context.
@nl
P2093
P2860
P1433
P1476
Outcomes and costs of Ranibizu ...... ealth-service research context
@en
P2093
Eva Blozik
Livia Faes
Lucas M Bachmann
Martin K Schmid
Maximilian Kuhn
Michael A Thiel
Nicolas S Bodmer
Oliver Reich
Silvan Locher
P2860
P2888
P356
10.1186/S12886-018-0731-4
P577
2018-02-27T00:00:00Z
P6179
1101248935